Drug Shortage Report for GLICLAZIDE MR

Last updated on 2024-11-12 History
Report ID 241793
Drug Identification Number 02524856
Brand name GLICLAZIDE MR
Common or Proper name GLICLAZIDE MR
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) GLICLAZIDE
Strength(s) 30MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-11-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-11-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2024-11-12 French Compare
v14 2024-11-12 English Compare
v13 2024-11-12 French Compare
v12 2024-11-12 English Compare
v11 2024-11-12 French Compare
v10 2024-11-12 English Compare
v9 2024-11-02 English Compare
v8 2024-11-01 French Compare
v7 2024-11-01 English Compare
v6 2024-11-01 French Compare
v5 2024-11-01 English Compare
v4 2024-11-01 English Compare
v3 2024-11-01 English Compare
v2 2024-11-01 French Compare
v1 2024-11-01 English Compare

Showing 1 to 15 of 15